asic4b Antibody

What is ASIC4 and what is its cellular distribution?

ASIC4 belongs to the superfamily of acid-sensing ion channels, which are proton-gated, amiloride-sensitive sodium channels. Unlike other ASIC family members, ASIC4 has no proton-gated channel activity in vitro . The protein is predominantly expressed in the pituitary gland, with weaker expression in the brain, vestibular system, and organ of Corti . At the subcellular level, heterologously expressed ASIC4 primarily resides in intracellular endosomal compartments rather than at the plasma membrane . Research has shown that ASIC4 specifically accumulates in early endosome-related structures, as evidenced by its co-localization with early endosomal markers like Rab5 and EEA1 .

How does ASIC4 differ from other ASIC family members?

ASIC4 differs from other ASIC family members in several key aspects:

• Subcellular localization: While other ASICs primarily function as plasma membrane channels, ASIC4 predominantly localizes to early endosome-related organelles .

• Channel activity: ASIC4 lacks the proton-gated channel activity characteristic of other ASIC family members .

• Structural determinants: The amino-terminus of ASIC4 is crucial for its endosomal localization, as demonstrated by chimera studies with ASIC2a .

• Physiological function: Rather than direct acid sensing, ASIC4 appears to play roles in endosomal trafficking and may influence learning and synaptic plasticity .

What are the key considerations when selecting an ASIC4 antibody for my research?

When selecting an ASIC4 antibody for research applications, consider the following factors:

• Epitope specificity: Different antibodies target different regions of ASIC4. For example, Alomone Labs' antibody targets amino acids 7-26 of rat ASIC4 , while NSJ Bioreagents' antibody targets amino acids 23-52 of human ASIC4 .

• Species reactivity: Ensure the antibody recognizes ASIC4 in your species of interest. Available antibodies have varied reactivity to human, mouse, and rat ASIC4 .

• Application compatibility: Verify the antibody has been validated for your specific application (WB, IHC, ELISA, etc.) .

• Clonality: Most commercially available ASIC4 antibodies are polyclonal, typically from rabbit origin .

• Isoform specificity: Consider whether the antibody detects all ASIC4 isoforms, as alternative splicing results in different isoforms .

How can I validate the specificity of an ASIC4 antibody in my experimental system?

To validate ASIC4 antibody specificity, implement these methodological approaches:

• Blocking peptide controls: Use the peptide antigen (e.g., Alomone Labs' ASIC4 Blocking Peptide) to pre-adsorb the antibody before application. This should eliminate specific staining in Western blot or immunohistochemistry applications .

• Knockout/knockdown validation: Compare antibody reactivity in wild-type versus ASIC4 knockout or knockdown samples.

• Recombinant protein expression: Overexpress tagged ASIC4 (e.g., GFP-ASIC4) and confirm co-detection with the antibody .

• Multiple antibody comparison: Use antibodies from different sources targeting different epitopes to confirm consistent detection patterns.

• Molecular weight verification: Confirm that detected bands match the expected molecular weight of ASIC4 (approximately 70 kDa for human ASIC4) .

What are the optimal conditions for using ASIC4 antibodies in Western blot analysis?

For optimal Western blot performance with ASIC4 antibodies:

• Sample preparation:

  • For tissue samples: Homogenize in ice-cold lysis buffer containing protease inhibitors

  • For cell lines: Lyse cells in RIPA buffer with 1% protease inhibitor cocktail

• Protocol optimization:

  • Protein loading: 20-50 μg per lane is typically sufficient

  • Dilution ratios: Start with 1:200-1:1000 depending on the specific antibody

  • Incubation time: 2 hours at room temperature or overnight at 4°C

  • Secondary antibody: HRP-conjugated anti-rabbit IgG (1:5000-1:10000)

  • Blocking solution: 5% non-fat dry milk or BSA in TBST

• Controls:

  • Include positive controls such as pituitary tissue or transfected cells expressing ASIC4

  • Use blocking peptide controls to confirm specificity

  • Expected band size is approximately 70 kDa, though this may vary by species and isoform

How can I optimize immunohistochemical detection of ASIC4 in different tissue types?

For successful immunohistochemical detection of ASIC4:

• Tissue preparation:

  • Fixation: 4% paraformaldehyde is generally suitable

  • For nervous tissue (brain, carotid body): Careful fixation timing is critical to preserve epitope accessibility

• Antigen retrieval:

  • Heat-induced epitope retrieval in citrate buffer (pH 6.0) for 15-20 minutes

  • For tissues with high fat content, consider additional permeabilization steps

• Protocol optimization:

  • Primary antibody dilution: Begin with 1:100-1:500 dilution

  • Incubation time: Overnight at 4°C typically yields best results

  • Detection method: Both fluorescent and chromogenic detection systems work with ASIC4 antibodies

• Controls and validation:

  • Include known positive tissues (pituitary gland, specific brain regions)

  • Use blocking peptide controls

  • Compare with in situ hybridization results where available

• Special considerations:

  • ASIC4 expression can be heterogeneous within tissues; for example, in the carotid body, ASIC4 immunoreactivity is limited to some isolated type I glomus cells and nerve profiles

How can I distinguish between membranous and endosomal ASIC4 in my experimental system?

Given that ASIC4 predominantly localizes to early endosomal compartments, distinguishing between membrane and endosomal pools requires specialized approaches:

• Subcellular fractionation:

  • Separate membrane, cytosolic, and endosomal fractions using differential centrifugation

  • Confirm fraction purity using markers for plasma membrane (Na+/K+-ATPase), early endosomes (EEA1, Rab5), and other compartments

  • Analyze ASIC4 distribution across fractions by Western blot

• Confocal microscopy with co-localization analysis:

  • Co-stain cells with ASIC4 antibody and markers for different compartments:

    • Early endosomes: Rab5, EEA1

    • Late endosomes: Rab7

    • Lysosomes: LAMP1

    • Recycling endosomes: Rab11

    • ER: PDI

    • Golgi: Giantin

  • Quantify co-localization using Pearson's correlation coefficient (PCC) as demonstrated in previous studies

  • Studies show strong co-localization with Rab5 (PCC = 0.43 ± 0.06) but not with Rab7, LAMP1, or Rab11 (PCC values close to zero)

• Live-cell imaging:

  • Generate fluorescently tagged ASIC4 constructs (e.g., GFP-ASIC4)

  • Combine with endosomal markers to track trafficking in real-time

What structural domains of ASIC4 are important for its subcellular localization, and how can I investigate them?

Research has identified key structural determinants of ASIC4 localization:

• N-terminal domain importance:

  • The amino-terminus of ASIC4 is crucial for its endosomal localization

  • Chimeric studies showed that replacing the N-terminus of ASIC4 with that of ASIC2a (ASIC4-Nterm2a) abolished endosomal localization

  • Conversely, adding the ASIC4 N-terminus to ASIC2a (ASIC2a-Nterm4) directed the protein to endosomal vesicles

• Investigation methods:

  • Chimeric proteins: Generate constructs swapping domains between ASIC4 and other ASIC family members

  • Site-directed mutagenesis: Target specific motifs like di-leucine motifs (LL29/30 and LL519/520) or di-arginine motifs (position 478)

  • Truncation constructs: Create N- or C-terminal truncations to map required regions

• Trafficking motifs:

  • Di-leucine motifs do not appear critical for ASIC4 endosomal localization, as mutating these (LL29AA and LL519AA) did not alter localization patterns

  • A C-terminal di-arginine motif at position 478 seems important for ASIC4 distribution

• Visualization methods:

  • Fluorescent protein tagging (GFP, mCherry) followed by confocal microscopy

  • Immunofluorescence with domain-specific antibodies

  • Super-resolution microscopy for detailed subcellular localization

What is the role of ASIC4 in neuronal function and synaptic plasticity?

Recent research has begun to elucidate ASIC4's role in neuronal function:

• Learning and memory:

  • Overexpression of ASIC4 in the hippocampus of Follistatin (Fst) knockout mice rescues learning deficits

  • ASIC4-overexpressing Fst KO mice show improved performance in water maze training and T-maze tests

  • ASIC4 overexpression reverses the impairment of long-term potentiation (LTP) in Fst KO mice

• Proposed mechanisms:

  • ASIC4 may influence endosomal trafficking of neurotransmitter receptors or synaptic proteins

  • It could regulate neuronal excitability indirectly, possibly by interacting with other ASIC family members

  • ASIC4 expression is regulated by Follistatin, suggesting a role in activity-dependent plasticity

• Research approaches:

  • Viral-mediated gene transfer (e.g., AAV-CB-ASIC4) for targeted overexpression

  • Electrophysiological recording to assess impacts on synaptic transmission and plasticity

  • Behavioral testing to evaluate cognitive effects

How can I investigate potential interactions between ASIC4 and other ASIC family members?

To study interactions between ASIC4 and other ASIC proteins:

• Co-immunoprecipitation (Co-IP) approaches:

  • Use ASIC4-specific antibodies to pull down protein complexes

  • Probe for other ASIC family members (ASIC1, ASIC2, ASIC3)

  • Consider crosslinking to stabilize transient interactions

  • Include appropriate controls (IgG control, lysates from cells not expressing ASIC4)

• Proximity ligation assay (PLA):

  • This technique allows visualization of protein interactions in situ

  • Use antibodies against ASIC4 and other ASIC family members

  • Quantify interaction signals in different subcellular compartments

• Fluorescence resonance energy transfer (FRET):

  • Generate fluorescently tagged constructs (e.g., ASIC4-CFP and ASIC1-YFP)

  • Measure energy transfer as an indicator of close proximity

  • Analyze in live cells to capture dynamic interactions

• Functional studies:

  • Co-expression of ASIC4 with other ASIC subtypes in heterologous systems

  • Electrophysiological recording to assess changes in channel properties

  • Trafficking studies to determine if ASIC4 affects surface expression of other ASICs

• Relevance in native tissues:

  • The human carotid body shows immunoreactivity for all ASIC isoforms, including ASIC4, suggesting potential for interactions in vivo

What are common challenges in detecting ASIC4 in tissue samples, and how can I overcome them?

Researchers face several challenges when detecting ASIC4:

• Low expression levels:

  • ASIC4 is weakly expressed in many tissues except the pituitary gland

  • In the human carotid body, ASIC4 immunoreactivity was described as "limited" and "in some isolated cells"

  • Solution: Optimize protein loading, use signal amplification methods, consider enrichment of relevant cell populations

• Antibody specificity:

  • Cross-reactivity with other ASIC family members is possible

  • Solutions:

    • Always include blocking peptide controls

    • Compare results with multiple antibodies targeting different epitopes

    • Validate with genetic approaches (knockout/knockdown models)

• Heterogeneous expression patterns:

  • ASIC4 distribution can vary significantly within a tissue

  • Solution: Use serial sections, multiple imaging fields, and quantitative analysis methods to account for heterogeneity

• Detection methodology:

  • For Western blot: More sensitive detection systems (ECL Prime, SuperSignal West Femto) may be required

  • For IHC/IF: Tyramide signal amplification or high-sensitivity fluorophores can enhance detection

• Tissue preparation:

  • Overfixation can mask epitopes

  • Solution: Optimize fixation protocols or test multiple antigen retrieval methods

How can I address inconsistent results between different detection methods for ASIC4?

When facing discrepancies between different detection methods:

• Reconcile Western blot and immunohistochemistry differences:

  • Western blot detects denatured protein and may recognize epitopes hidden in fixed tissues

  • IHC preserves spatial information but may suffer from epitope masking

  • Solution: Use complementary approaches and optimize each protocol independently

• Comparison with mRNA detection:

  • Combine protein detection with in situ hybridization or RT-PCR

  • This can help distinguish between transcriptional and post-transcriptional regulation

  • Example from literature: ASIC4 mRNA overexpression in the hippocampus was confirmed by both in situ hybridization and real-time PCR

• Integration of multiple techniques:

  • Subcellular fractionation followed by Western blot

  • Live-cell imaging with tagged constructs

  • Proximity ligation assays for protein-protein interactions

• Controls to include:

  • Recombinant protein expression

  • Tissues with known high expression (pituitary gland)

  • Competitive blocking with immunizing peptide

  • Sample preparation controls (e.g., detection of housekeeping proteins)

• Quantification methods:

  • Use multiple independent methods to quantify signals

  • For microscopy: Consider pixel intensity, area coverage, and cell counting approaches

  • For Western blot: Normalize to appropriate loading controls